Raymond P. Goodrich

The Infectious Disease Research Center provides a safe, secure, state of the art facility for university investigators, government scientists and industry representatives to collaboratively research the basic biology, biochemistry, molecular biology and epidemiology of bacteria and viruses that cause human and animal diseases. The Center provides the highest quality research environment for developing new scientific discoveries, vaccines, methods of diagnosis, and therapeutic agents for infectious agents. Colorado State University is among the world’s leaders in researching West Nile Virus, drug-resistant Tuberculosis, Yellow Fever, Dengue, Hantavirus, Plague, Tularemia and other diseases.

The Executive Director has responsibility and oversight of the Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) facility. BioMARC is an FDA-inspected not-for-profit service entity at Colorado State University (CSU) that specializes in the production of biologic products that require high containment facilities, including Biosafety Level 3 (BSL-3), CDC Tier 1 select agents, as well as spore forming microorganisms. BioMARC offers product lifecycle support for manufacturing in biological therapeutics, vaccines and diagnostic products.

Dr. Goodrich formerly served as Vice President of Scientific and Clinical Affairs and Chief Scientific Officer, Blood Bank Technologies, for Terumo BCT, a leading global medical device manufacturer based in The United States. His responsibilities included oversight of research and development programs in the field of blood product processing and blood safety. He has worked in medical research for over 29 years during which he has managed research staff and development programs in the fields of transfusion and transplantation medicine and pathogen reduction technologies. He has been awarded over 50 patents covering technology in these areas and has co-authored over 200 peer reviewed articles and abstracts. He has also served as the Principal Investigator for grants totaling over $40M from the United States Department of Defense (Congressionally Designated Medical Research Program) for the development of a transportable blood treatment system. He is a recipient of the Order of Military Medical Merit (honorary) for his work in supporting blood transfusion efforts for military personnel.

He is an active member of several professional organizations including the American Chemical Society, the American Association of Blood Banks. He has served on the Working Party on Transfusion Transmitted Diseases for the International Society of Blood Transfusion and the Working Party on Transfusion Transmissible Diseases of the American Association of Blood Banks. He has also served as a member of the Medical Device Innovation Consortium (MDIC), an organization bringing together regulatory authorities and clinical and scientific experts in The United States to advance the field of regulatory science and enhance innovation in the medical device industry in The United States. Dr. Goodrich has also held a position as an Adjunct Professor of Chemistry at The Ohio State University since 2005. He also holds a faculty position as Professor in the Department of Microbiology, Immunology and Pathology at Colorado State University.